Source link : https://www.newshealth.biz/health-news/scrap-clozapines-rems-program-fda-advisors-say/
A joint FDA advisory committee on Tuesday overwhelming voted to eliminate the risk evaluation and mitigation strategy (REMS) program designed around the risk for severe neutropenia associated with clozapine, a drug used to treat schizophrenia and schizoaffective disorder. All but one of the 15 voting panel members said the current requirements for prescribers to document […]
Author : News Health
Publish date : 2024-11-20 14:26:13
Copyright for syndicated content belongs to the linked Source.